Saxonov Serge Insider Trades & Stock Holdings
Saxonov Serge, Chief Executive Officer at 10x Genomics, Inc. has 1 Form 4 trade on file since Sep 22, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($2.03M), net -$2.03M. Latest filing: disposed of 25K shares of $TXG on Sep 22, 2026 at $81.22.
- Trades on file
- 1
- Open-market bought
- $0
- Open-market sold
- $2.03M
- Net open-market
- -$2.03M
- Latest filing
- Sep 22, 2026
All insider trades by Saxonov Serge
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $TXG | Sell (Open-market sale) 10b5-1 | 25K | $81.22 | $2.03M | +11.6% | Chief Executive Officer | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Saxonov Serge traded
Frequently asked questions
Has Saxonov Serge been buying or selling stock?
Saxonov Serge has 0 open-market purchases and 1 open-market sale on file, net -$2.03M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Saxonov Serge's latest insider trade?
disposed of 25K shares of $TXG on Sep 22, 2026 at $81.22.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.